Contract manufacturer Minnetronix Medical launches its first in-house product, MindsEye

Minnetronix Medical’s MindsEye expandable port [Photo courtesy of Minnetronix Medical]

Minnetronix Medical has launched MindsEye, making it the first medical device that the contract developer and manufacturer has conceived and commercialized.

St. Paul-based Minnetronix Medical’s MindsEye is the first expandable brain access port on the market. The FDA cleared the device under the 510(k) pathway in August 2020.

The minimally invasive device gives neurosurgeons deep brain access and visualization as they treat strokes, cancer and other conditions. The device features a flexible sheath made of cyclic olefin copolymer (COC) and an aluminum obturator. MindsEye won the Minnesota Technology Association’s TEKNE award for best medical technology and device in 2021.

“Its benefits to neurosurgeons — such as expandability, easier insertion and removal, and transparency that minimizes glare …

Read more
  • 0

A neurologist dishes on the migraine treatment landscape

Migraine image courtesy of Pixabay

Migraines are a prevalent condition, affecting about one billion people across the world. “In the U.S., about 13% of the population experiences migraine headaches regularly,” said Dr. Alexander Feoktistov, a neurologist at the Synergy Integrative Headache Center in Chicago. 

In the following interview, Feoktistov shed light on the prevalence of the condition and shares his thoughts on the overall treatment landscape. A forthcoming article will touch on how migraine treatments have evolved over the past two decades, focusing on the impact of recently introduced therapies. 

Could you briefly summarize how you diagnose migraines? 

Feoktistov: Migraine headaches typically start in childhood or during adolescence and frequently continue throughout most of the patient’s life. We sometimes see outliers when people start experiencing headaches later …

Read more
  • 0